Natasha Giordano | President, Chief Executive Officer |
Rita O’Connor | Chief Financial Officer |
Asif Ali | Preventative Cardiologist |
Janet Barth | Vice President, Investor Relations |
Leland Gershell | Oppenheimer |
Jason Butler | JMP Securities |
Ladies and gentlemen, thank you for standing by and welcome to PLx Pharma’s third quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode.
Following the presentation, there will be a question and answer session. Please be advised that today’s conference may be recorded. I would now like to hand the conference over to Janet Barth, PLx’s Vice President of Investor Relations and Corporate Communications.